Mansooreh Ahmadian
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mansooreh Ahmadian has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Kimberly Jordan
Department of Immunology & Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
81 shared publications - Aaron Clauset
University of Colorado Boulder
80 shared publications - Benjamin G. Bitler
Department of OB/GYN, The University of Colorado Anschutz Medical Campus, Aurora, Colorado
80 shared publications - Christian Rickert
Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA
80 shared publications - Jennifer K. Richer
University of Colorado Anschutz Medical Campus 1 Department of Pathology Aurora, Colorado
80 shared publications - Junxiao Hu
Biostatistics Core, University of Colorado Cancer Center, 1665 Aurora Court, Suite 1032, Aurora, CO 80238, USA; Department of Pediatrics, University of Colorado School of Medicine, 13123 E 16th Ave, Aurora, CO 80045, USA
80 shared publications
Latest Publications
- Open Access
Large-scale automated detection reveals pervasive sex imbalance in biomedical research
Sex is a critical biological variable that impacts disease risk, progression, and treatment response across virtually every organ system. However, decades of biomedical research have relied primarily on male study subjects, leaving large gaps in our understanding of female-specific disease biology. Quantifying the extent of this imbalance across thousands of disease areas and millions of publicly available biological samples has remained computationally intractable. Here, we present a multimodal computational framework that infers the biological sex of ∼230,000 publicly available human transcriptome samples and links inferred sex labels to disease terms extracted from ∼9,000 associated study records and ∼5,000 publication abstracts to quantify sex imbalance at scale. Applying this approach revealed that the majority of disease terms with the largest research-derived sex imbalance are skewed toward male representation, including areas with no known biological justification for that imbalance. After adjusting for global sex-specific disease prevalence to isolate biologically unjustified imbalance, up to 58% of all disease terms showed male-leaning association. Diseases including glioblastoma, cirrhosis, idiopathic pulmonary fibrosis, and schizophrenia emerged as critically understudied in females despite affecting both sexes comparably. These findings provide a principled, data-driven basis for prioritizing compensatory research efforts and offer a reusable framework for ongoing monitoring of sex representation in the biomedical literature. Highlights: Skewed male and female study subject representation in biomedical research is the result of decades of studies conducted without adequate female representation. We developed an automated, multimodal framework to estimate the sex imbalance across thousands of disease terms using metadata from ∼230,000 transcriptomics samples and their associated ∼9,000 studies and ∼5,000 publications. Our approach identifies non-sex-specific disease research areas that have been studied using an unbalanced sex demographic. These areas need compensatory and balanced studies to understand sex differences.
Open AccessLarge-scale automated detection reveals pervasive sex imbalance in biomedical research
Sex is a critical biological variable that impacts disease risk, progression, and treatment response across virtually every organ system. However, decades of biomedical research have relied primarily on male study subjects, leaving large gaps in our understanding of female-specific disease biology. Quantifying the extent of this imbalance across thousands of disease areas and millions of publicly available biological samples has remained computationally intractable. Here, we present a multimodal computational framework that infers the biological sex of ∼230,000 publicly available human transcriptome samples and links inferred sex labels to disease terms extracted from ∼9,000 associated study records and ∼5,000 publication abstracts to quantify sex imbalance at scale. Applying this approach revealed that the majority of disease terms with the largest research-derived sex imbalance are skewed toward male representation, including areas with no known biological justification for that imbalance. After adjusting for global sex-specific disease prevalence to isolate biologically unjustified imbalance, up to 58% of all disease terms showed male-leaning association. Diseases including glioblastoma, cirrhosis, idiopathic pulmonary fibrosis, and schizophrenia emerged as critically understudied in females despite affecting both sexes comparably. These findings provide a principled, data-driven basis for prioritizing compensatory research efforts and offer a reusable framework for ongoing monitoring of sex representation in the biomedical literature. Highlights: Skewed male and female study subject representation in biomedical research is the result of decades of studies conducted without adequate female representation. We developed an automated, multimodal framework to estimate the sex imbalance across thousands of disease terms using metadata from ∼230,000 transcriptomics samples and their associated ∼9,000 studies and ∼5,000 publications. Our approach identifies non-sex-specific disease research areas that have been studied using an unbalanced sex demographic. These areas need compensatory and balanced studies to understand sex differences.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S10 from The Spatial Structure of the Tumor Immune Microenvironment Can Explain and Predict Patient Response in High-Grade Serous Carcinoma
Fig S10. Example antibody staining images. Raw antibody staining images are shown here for an example FOV (FOV ID 9).
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S10 from The Spatial Structure of the Tumor Immune Microenvironment Can Explain and Predict Patient Response in High-Grade Serous Carcinoma
Fig S10. Example antibody staining images. Raw antibody staining images are shown here for an example FOV (FOV ID 9).
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Table S14 from The Spatial Structure of the Tumor Immune Microenvironment Can Explain and Predict Patient Response in High-Grade Serous Carcinoma
Table S14. Ranking of feature importance in the random forest model for only primary tumor samples. Ranking of median Gini importance values for all features across 500 evaluations predicting OS and PFS, with the model trained only on primary tumor samples.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S14 from The Spatial Structure of the Tumor Immune Microenvironment Can Explain and Predict Patient Response in High-Grade Serous Carcinoma
Table S14. Ranking of feature importance in the random forest model for only primary tumor samples. Ranking of median Gini importance values for all features across 500 evaluations predicting OS and PFS, with the model trained only on primary tumor samples.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S22 from The Spatial Structure of the Tumor Immune Microenvironment Can Explain and Predict Patient Response in High-Grade Serous Carcinoma
Fig S22. Random forest feature importance results split by feature type - PFS. Feature importance results for progression-free survival show in Figure 7B, split by feature type and split by subtype for spatial network features.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S22 from The Spatial Structure of the Tumor Immune Microenvironment Can Explain and Predict Patient Response in High-Grade Serous Carcinoma
Fig S22. Random forest feature importance results split by feature type - PFS. Feature importance results for progression-free survival show in Figure 7B, split by feature type and split by subtype for spatial network features.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Table S10 from The Spatial Structure of the Tumor Immune Microenvironment Can Explain and Predict Patient Response in High-Grade Serous Carcinoma
Table S10. Correlation coefficients between other cell type percentages and tumor cell percentages. Full list of Pearson correlation coefficients between tumor cell percentage and cell type percentage, two-sided p-values and false discovery rate adjusted p-values are reported, with significance determined by the latter.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S10 from The Spatial Structure of the Tumor Immune Microenvironment Can Explain and Predict Patient Response in High-Grade Serous Carcinoma
Table S10. Correlation coefficients between other cell type percentages and tumor cell percentages. Full list of Pearson correlation coefficients between tumor cell percentage and cell type percentage, two-sided p-values and false discovery rate adjusted p-values are reported, with significance determined by the latter.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S14 from The Spatial Structure of the Tumor Immune Microenvironment Can Explain and Predict Patient Response in High-Grade Serous Carcinoma
Fig S14. Median neighbor distances in the spatial networks. Heatmap of the median distances (μm) between spatial network neighbors of pairs of cell types aggregated across all edges included in the final set of samples.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S14 from The Spatial Structure of the Tumor Immune Microenvironment Can Explain and Predict Patient Response in High-Grade Serous Carcinoma
Fig S14. Median neighbor distances in the spatial networks. Heatmap of the median distances (μm) between spatial network neighbors of pairs of cell types aggregated across all edges included in the final set of samples.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S19 from The Spatial Structure of the Tumor Immune Microenvironment Can Explain and Predict Patient Response in High-Grade Serous Carcinoma
Fig S19. Random forest predictive performance results for only primary tumor samples. Main text Figure 6 repeated with random forest models trained only on primary tumor samples for the same binary outcome variables of low vs. high OS and PFS (n = 69).
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S19 from The Spatial Structure of the Tumor Immune Microenvironment Can Explain and Predict Patient Response in High-Grade Serous Carcinoma
Fig S19. Random forest predictive performance results for only primary tumor samples. Main text Figure 6 repeated with random forest models trained only on primary tumor samples for the same binary outcome variables of low vs. high OS and PFS (n = 69).
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S20 from The Spatial Structure of the Tumor Immune Microenvironment Can Explain and Predict Patient Response in High-Grade Serous Carcinoma
Fig S20. Random forest feature importance results for only primary tumor samples. Main text Figure 7 with random forest models trained only on primary tumor samples for the same binary outcome variables of low vs. high OS and PFS (n = 69).
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S20 from The Spatial Structure of the Tumor Immune Microenvironment Can Explain and Predict Patient Response in High-Grade Serous Carcinoma
Fig S20. Random forest feature importance results for only primary tumor samples. Main text Figure 7 with random forest models trained only on primary tumor samples for the same binary outcome variables of low vs. high OS and PFS (n = 69).
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S4 from The Spatial Structure of the Tumor Immune Microenvironment Can Explain and Predict Patient Response in High-Grade Serous Carcinoma
Fig S4. Random forest predictive performance results with increased spatial network trimming threshold. Main text Figure 6 repeated if edges in spatial networks are trimmed with a higher threshold of 100 pixels (∼48.8 μm).
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from The Spatial Structure of the Tumor Immune Microenvironment Can Explain and Predict Patient Response in High-Grade Serous Carcinoma
Fig S4. Random forest predictive performance results with increased spatial network trimming threshold. Main text Figure 6 repeated if edges in spatial networks are trimmed with a higher threshold of 100 pixels (∼48.8 μm).
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Table S11 from The Spatial Structure of the Tumor Immune Microenvironment Can Explain and Predict Patient Response in High-Grade Serous Carcinoma
Table S11. Univariate Cox regression results for only primary tumor samples. Univariate Cox regression results for OS and PFS for all features, restricted to only primary tumor samples.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S11 from The Spatial Structure of the Tumor Immune Microenvironment Can Explain and Predict Patient Response in High-Grade Serous Carcinoma
Table S11. Univariate Cox regression results for only primary tumor samples. Univariate Cox regression results for OS and PFS for all features, restricted to only primary tumor samples.